Molecular Monitoring After Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results From the Nordic Mantle Cell Lymphoma Studies (MCL2 and McL3) With Median Follow-Up of 8.5 Years
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2016.12.634
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
Elsevier BV